Skip to content

The Effect of 10 Weeks of TRX Training with Chamomile Extract Supplement on Serum Levels of lipocalin 2, Oxidative Stress Factors and Glycemic Indices in Type 2 Diabetic Women

The Effect of TRX Training with Chamomile Extract Supplement on Serum Levels of lipocalin 2, Oxidative Stress Factors and Glycemic Indices in Type 2 Diabetic Women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240929063198N1
Enrollment
48
Registered
2024-10-02
Start date
2024-09-30
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: Intervention group 1 (TRX + Chamomile): This group will perform 3 sessions of TRX exercises every week for 10 weeks. Exercise intensity will be monitored using the

Sponsors

Shahid Madani University of Azerbaijan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having type 2 diabetes (at least 6 months history of diabetes) Age range 40 to 60 years being female Use of blood sugar lowering drugs, people with dyslipidemia who continue their usual treatment.

Exclusion criteria

Exclusion criteria: Use of insulin No smoking and alcohol Absence of pregnancy and breastfeeding Allergy to chamomile Absence of kidney, liver, heart, thyroid, hemorrhagic diseases and malignancies.

Design outcomes

Primary

MeasureTime frame
Serum level of lipocalin 2. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Malondialdehyde serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Glutathione peroxidase serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Superoxide desmutase serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Total antioxidant capacity serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Fasting blood sugar serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: Enzymatic method.;Fasting insulin serum level. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Glycosylated hemoglobin (HbA1C). Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: It is measured using a laboratory kit and ELISA method.;Insulin resistance. Timepoint: 48 hours before the start of the intervention and after the 10-week period. Method of measurement: Calculation based on the formula.

Secondary

MeasureTime frame
Maximum oxygen consumption (vo2max). Timepoint: 48 hours before the intervention and after the 10-week period. Method of measurement: Using Queen's step test and formula.;Body fat percentage. Timepoint: 48 hours before the intervention and after the 10-week period. Method of measurement: Using calipers and the three-point formula.;Waist to hip ratio (WHR). Timepoint: 48 hours before the intervention and after the 10-week period. Method of measurement: Using meters and formulas.;Body composition index (BMI). Timepoint: 48 hours before the intervention and after the 10-week period. Method of measurement: Using the formula.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahlul Ghorbanian

Shahid Madani University of Azerbaijan

b.gorbanian@gmail.com+98 41 3432 7500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026